Elsevier

Neuroscience Research

Volume 48, Issue 1, January 2004, Pages 93-100
Neuroscience Research

Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline

https://doi.org/10.1016/j.neures.2003.10.002Get rights and content

Abstract

The structural substrates for age-associated cognitive and motor slowing are not known, but age-related white matter changes, such as ubiquitin (UBQ)-immunoreactive granular degeneration of myelin, might contribute to this slowing. To address this hypothesis we measured immunoreactivity for UBQ and myelin basic protein (MBP) in frontal white matter of age-, sex- and postmortem interval-matched cases with no cognitive impairment (NCI; N=12), mild cognitive impairment (MCI; N=14) and Alzheimer disease (AD; N=12). There were no significant correlations between UBQ in white matter and cognitive measures, but MBP was significantly lower in AD compared with NCI and MCI. MBP correlated with overall cognition as assessed by neuropsychological summary scores, as well as with timed cognitive tests and those that reflect frontal functions. An age-related decrease in MBP immunoreactivity was detected in NCI cases (r=0.71). These results support the hypothesis that white matter pathology may contribute to age-associated decline in cognition.

Introduction

Myelin pathology is a common feature of aging and is also seen in age-related degenerative diseases. A common form of myelin pathology in aging is granular degeneration of myelin. Granular degeneration of myelin was first observed at the ultrastructural level by Terry et al. (1964) in biopsies of Alzheimer’s disease (AD) and was further characterized by Rees in normal brain biopsies (Rees, 1976). Structurally, it is characterized by expansions within the myelin sheath that contain heterogeneous, dense and amorphous material. The extent of granular degeneration of myelin was only realized with the advent of ubiquitin (UBQ) immunocytochemistry (Dickson et al., 1990). Granular degeneration of white matter is almost universal in elderly brains, but uncommon in young brains (Dickson et al., 1990, Pappolla et al., 1989). Developmentally, ubiquitin-immunoreactive granular degeneration of myelin is detected as early as the third decade of life (Dickson et al., 1990). No concerted effort has been made to rigorously and objectively measure the amount of ubiquitin-immunoreactivity in white matter as a function of age. Nor has there been any attempt to correlate this observation with indices of motor and mental impairment.

Ubiquitin is a member of the family of low molecular weight (∼8.5 kDa) heat shock proteins that serves a vital role in physiologic and pathologic protein turnover (Ciechanover et al., 2000). Cell stress mediated by oxidative mechanisms is common in aging (Stadtman, 1992), and is often associated with protein denaturation, which is subject to proteolysis. In a variety of different tissue types, high molecular weight (>60 kDa) ubiquitin conjugates progressively increase with age (Goto et al., 2001). Age-related increases in ubiquitin conjugation may be a response to age-related protein damage. The proteins to be degraded by this system are covalently modified by ubiquitin and eventually targeted for degradation via either proteasomes or lysosomes (Ciechanover et al., 2000). Of particular interest is the fact that ubiquitin is associated with a number of cytological alterations in aging and in degenerative disorders (Lowe et al., 1988). Moreover, ubiquitin immunoreactivity is increased in cortical gray matter in AD, presumably due to the presence of ubiquitin in neurofibrillary tangles and neuritic plaques (Wang et al., 1991; Wang et al., 2001a, Wang et al., 2001b; Mori et al., 1987).

Myelin disorders of all types are known to be associated with slowing of nerve conduction velocity. The major structural protein of myelin is myelin basic protein (MBP), which is a family of proteins consisting of multiple polypeptide chains varying in molecular weight from 14 to 21.5 kDa (Givogri et al., 2000). At least four isoforms of MBP have been identified in humans (Kamholz et al., 1986). The gene encoding MBP has been mapped to chromosome 18 (Sparkes et al., 1987). Although the function of MBP is still largely unknown, it is thought to play an important role in compaction of the myelin sheath. Given widespread alteration of myelin in the aged brain, we hypothesized that changes in MBP would correlate with measures of motor and mental slowing that are virtually inevitable with aging.

In the present study, ubiquitin and MBP immunoreactivities were measured in frontal white matter of subjects participating in the Religious Orders Study, a longitudinal clinicopathologic study, including subjects with no cognitive impairment (NCI), mild cognitive impairment (MCI) and clinically probable AD. To explore the possible associations of changes in ubiquitin and MBP on cognition, the relationship of ubiquitin and MBP to various clinical and neuropsychological variables was analyzed.

Section snippets

Antibodies and reagents

Anti-human MBP monoclonal antibody was purchased from Roche (Cat#: 1118099, currently available from Chemicon International, Inc., Cat#: MAB5274). Monoclonal antibody Ubi1 was a kind gift from Dr. Gerry Shaw (University of Florida) (Shaw and Chau, 1988) and was used in quantitative dot-blots of UBQ immunoreactivity. Alkaline phosphatase-conjugated goat anti-mouse and anti-rabbit antibodies, were purchased from Sigma (St. Louis, MO). Horseradish peroxidase (HRP) conjugated rabbit anti-mouse IgG1

UBQ immunoreactivity in gray and white matter

All cases had at least some UBQ immunoreactive pathology in frontal white matter as seen with ubiquitin immunohistochemistry (Fig. 1a). The amount of UBQ immunoreactivity in frontal gray matter and white matter was quantified with immuno-blots. There was considerably more UBQ immunoreactivity in white matter than gray matter in all samples (Fig. 1b), but there were no significant differences between AD, MCI or NCI (data not shown).

Myelin basic protein immunoreactivity in white matter

MBP immunoreactivity in AD was about 28% lower than in NCI and

Discussion

A common age-related change in the central nervous system is granular degeneration of myelin, which is best demonstrated by ubiquitin immunohistochemistry (Dickson et al., 1990). In developmental studies this change develops in early and mid-adulthood and is nearly universal in the elderly (Dickson et al., 1990). Given the advanced age of the subjects in the present study (>80 years of age), an age in which virtually all brains would be predicted to have abundant granular degeneration, it is

Acknowledgements

We are indebted to the altruism and support of the hundreds of nuns, priests and brothers from the following groups participating in the Religious Orders Study: Archdiocesan priests of Chicago, Dubuque, and Milwaukee; Benedictine Monks; Lisle, IL and Collegeville, MN; Benedictine Sisters of Erie; Erie PA; Benedictine Sisters of the Sacred Heart, Lisle, IL; Capuchins; Appleton, WI; Christian Brothers; Chicago, IL and Memphis, TN; Diocesan priests of Gary, IN; Dominicans; River Forest, IL;

References (38)

  • K.A. Ansari et al.

    Decreased myelin basic protein content of the aged human brain

    Neurology

    (1975)
  • D.A. Bennett et al.

    Metric properties of nurses’ ratings of parkinsonian signs with a modified unified Parkinson’s disease rating scale

    Neurology

    (1997)
  • D.A. Bennett et al.

    Natural history of mild cognitive impairment in older persons

    Neurology

    (2002)
  • H.H. Berlet et al.

    Studies of human myelin proteins during old age

    Mech. Ageing Dev.

    (1980)
  • A. Brun et al.

    A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study

    Ann. Neurol.

    (1986)
  • A. Ciechanover et al.

    The ubiquitin-mediated proteolytic pathway: modes of action and clinical implications

    J. Cell Biochem. Suppl.

    (2000)
  • S.T. DeKosky et al.

    Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

    Ann. Neurol.

    (2002)
  • D.W. Dickson et al.

    Ubiquitin-immunoreactive structures in normal brains: distribution and development aspects

    Lab. Invest.

    (1990)
  • M.F. Folstein et al.

    “Mini-mental state”: a practical method for grading the mental state of patients for the clinician

    J. Psychiatric Res.

    (1975)
  • M. Givogri et al.

    New insights on the biology of myelin basic protein genes: the neural-immune connection

    J. Neurosci. Res.

    (2000)
  • S. Goto et al.

    Implications of protein degradation in aging

    Ann. N.Y. Acad. Sci.

    (2001)
  • Han, X., M Holtzman, D., McKeel Jr., D.W., Kelley, J., Morris, J.C., 2002. Substantial sulfatide deficiency and...
  • J. Kamholz et al.

    Identification of three forms of human myelin basic protein by cDNA cloning

    Proc. Natl. Acad. Sci. U.S.A.

    (1986)
  • J.H. Kordower et al.

    Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment

    Ann. Neurol.

    (2001)
  • J. Lowe et al.

    Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease

    J. Pathol.

    (1988)
  • G. McKhann et al.

    Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease

    Neurology

    (1984)
  • S.S. Mirra et al.

    The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease

    Neurology

    (1991)
  • T.W. Mitchell et al.

    Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment

    J. Histochem. Cytochem.

    (2000)
  • T.W. Mitchell et al.

    Parahippocampal tau pathology in healthy aging

    Ann. Neurol.

    (2002)
  • Cited by (0)

    View full text